01
Sample Size Calculations & Power Optimization
Scientifically defensible sample size calculations and statistical power estimations tailored to study designs, minimizing trial costs while securing statistical significance.
Biostatistical Services in Chennai
Voxtur Clinical Research provides biostatistical services in Chennai, supporting clinical studies through statistical study design, clinical data analysis, sample size calculations, statistical programming and research reporting. These services help ensure accurate data interpretation, reliable study results and compliance with clinical research requirements.
End-to-End Quantitative Rigor
Biostatistical Services in Chennai
Convert complex clinical trial data into clear, defensible statistical evidence for global regulators. Voxtur Clinical Research delivers high-precision biostatistical services in Chennai across Phase I–IV clinical studies and BA/BE programs. From protocol-stage power calculations and pre-specified Statistical Analysis Plans (SAPs) to CDISC-compliant data modeling (SDTM/ADaM), interim DSMB reviews, and integrated summaries (ISS/ISE), we ensure your clinical development program withstands rigorous scrutiny by CDSCO, US FDA, and EMA review panels.
Design Partnership & Evidence
De-Risking Study Endpoints with Regulatory-Grade Biostatistics
In modern clinical trials, underpowered sample cohorts, ambiguous primary endpoints, and misaligned analytical methodologies represent major threats to drug development timelines. Even a clinically effective therapeutic molecule can fail regulatory clearance if statistical methodology does not account for dropouts, confounding variables, and inter-center variance early on.
Our specialized biostatistical services in Chennai embed expert statistical thinking directly into study architecture from day one. Voxtur collaborates closely with sponsors, medical writers, and clinical data managers to design statistically sound clinical protocols, justify targeted sample sizes, and establish robust, audit-proof Statistical Analysis Plans (SAPs).
Whether evaluating non-inferiority trials, complex oncology endpoints, or bioequivalence pharmacokinetics, our dedicated biostatisticians structure data in strict compliance with CDISC standards, turning raw case report forms into transparent, submission-ready datasets recognized worldwide.
100%
CDISC compliant deliverables (SDTM, ADaM, & Define.xml)
ICH E9 (R1)
Adherence to estimand frameworks and international regulatory guidelines
Zero-Lag
Streamlined statistical reporting between database lock and draft CSR
Audit-Ready
Validated SAS & R programming workflows for CDSCO, US FDA, & EMA submissions
Quantitative Solutions
What We Deliver in Biostatistical Services
Our biostatistics team covers the entire study trajectory, transforming clinical objectives into pre-specified analytical rigor and publication-grade reporting.
02
Statistical Review & Reporting (TLFs & CSR)
Independent data reviews and generation of fully validated Tables, Listings, and Figures (TLFs) integrated seamlessly into ICH E3 Clinical Study Reports.
03
Statistical Consulting & Protocol Design
Strategic consulting on study design, primary/secondary endpoint selection, randomization strategies, and estimand definitions from initial protocol drafts through submission.
04
Integrated Summaries of Safety & Efficacy (ISS / ISE)
Methodological pooling and cross-study meta-analyses to build submission-ready ISS and ISE modules for New Drug Applications (NDAs) and regulatory dossiers.
05
Interim Analysis & DSMB / DMC Support
Independent statistician support for Data Safety Monitoring Boards, including unblinded safety reviews, futility assessments, and group sequential analyses.
06
Statistical Analysis Plan (SAP) Development
Comprehensive, pre-specified SAP authoring, including mock shell designs, handling of missing data, sensitivity analyses, and derivation business logic.
Methodology & Workflow
Biostatistics Delivery Matrix Across Trial Phases
From early hypothesis formation to final regulatory defense, our biostatisticians enforce structured milestones to maintain analytical validity throughout your study.
| Development Phase | Core Deliverables Handled by Voxtur | Regulatory Benchmark |
|---|---|---|
| Protocol Formulation & Design | Hypothesis modeling, sample size derivation, dropout rate factoring, randomization schedules, and protocol statistical section drafting. | ICH E9 / E9 (R1) Compliance |
| SAP & Mock Shell Creation | Detailed SAP documentation, predefined handling of missing data and protocol deviations, and production of annotated mock TLF shells. | Finalized Prior to Unblinding |
| Data Standards & CDISC Modeling | SDTM mapping, ADaM analysis dataset programming, validation specifications, and automated Define.xml / Reviewer Guide generation. | FDA & PMDA Ready Standards |
| Interim & DSMB Reviews | Production of closed session safety packages, unblinded statistical monitoring, stopping-boundary calculations, and DMC liaison. | Independent Firewalled Oversight |
| Final Reporting & Archival | Production and quality control of final TLFs, double programming validation in SAS/R, statistical contribution to CSR, and audit trail archival. | Post-DB Lock Rapid Output |
The Voxtur Advantage
Why Global & Indian Sponsors Trust Voxtur Biostatistics
Design Partnership
We don't merely run code on closed databases; our biostatisticians guide trial methodology from the initial protocol draft to prevent structural flaws early.
Regulatory-Grade Output
Every algorithm, derivation, and summary table is produced using verified dual-programming quality checks built specifically for CDSCO, US FDA, and EMA review.
CDISC-Aligned Precision
We ensure complete traceability from raw electronic data capture (EDC) to SDTM and ADaM datasets, backed by comprehensive Define.xml and reviewer documentation.
Clarity in Reporting
Complex mathematical models and multi-arm trial outcomes are translated into clean, unambiguous summaries that clearly present clinical evidence to regulatory authorities.
Chennai Coverage
Biostatistical Services Across Tamil Nadu
Voxtur Clinical Research supports clinical research and biostatistical requirements across key locations in Tamil Nadu, including Chennai, Coimbatore, Madurai, Trichy and Salem. Biostatistical services cover study design, statistical analysis, clinical data interpretation and research reporting to support accurate and reliable clinical study outcomes.
Chennai
Clinical Research & Biopharmaceutical Studies
Biostatistical support for clinical research studies, including study design, sample size calculations, statistical analysis and clinical data interpretation.
Coimbatore & Tiruppur
Clinical Data Analysis & Reporting
Statistical analysis and data reporting support for clinical studies, helping researchers evaluate study results and interpret clinical data accurately.
Madurai & Tirunelveli
Clinical Trial Statistical Support
Biostatistical services covering statistical methods, data analysis and interpretation to support clinical trial planning and evaluation.
Trichy, Salem & Erode
Research Data Management & Statistical Reporting
Statistical reporting and clinical data evaluation to support research documentation, study assessments and evidence-based clinical research.
Frequently Asked Questions
Biostatistical Services in Chennai: Sponsor FAQ
Clear insights into statistical deliverables, regulatory compliance, and study planning workflows.
What is included in Voxtur’s Biostatistical Services in Chennai?
Our end-to-end biostatistical services include sample size and power calculation, randomization schedule generation, Statistical Analysis Plan (SAP) development, mock TLF shell generation, CDISC mapping (SDTM and ADaM), validated statistical programming in SAS and R, interim safety/futility reviews, DSMB support, ISS/ISE compilation, and statistical authoring for Clinical Study Reports (CSRs).
Why is early statistical input critical during protocol design?
Involving a biostatistician early ensures that your study endpoints are measurable, your sample size is appropriately powered to detect clinically meaningful differences, and your dropout assumptions reflect clinical reality. This prevents underpowered studies, costly protocol amendments, and ambiguity during regulatory evaluations.
How does Voxtur maintain CDISC alignment for regulatory submissions?
Our statistical programming team builds datasets according to current CDISC SDTM (Study Data Tabulation Model) and ADaM (Analysis Data Model) implementation guidelines. Deliverables undergo automated compliance checks and include validated Define.xml files, Reviewer’s Guides (SDRG/ADRG), and transparent code comments required for seamless US FDA, EMA, and CDSCO reviews.
Can Voxtur provide independent biostatistical support for interim analyses and DSMBs?
Yes. We act as an independent unblinded statistical team to execute interim efficacy and futility analyses, prepare blinded and unblinded safety reports for Data Safety Monitoring Boards (DSMB), and maintain strict data firewalls to ensure the study team and sponsor remain fully blinded.
Integrated Solutions
Related Clinical Research Services
Pair our biostatistical capabilities with our complete suite of clinical operations and regulatory consulting services.
Power Your Study
Partner with an Experienced Biostatistics Team in Chennai
Gain defensible quantitative evidence, streamline your CDISC data architecture, and navigate regulatory milestones with total confidence. Contact Voxtur Clinical Research to design your Statistical Analysis Plan.